These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28267047)

  • 61. Does Computerized Cognitive Behavioral Therapy Help People with Inflammatory Bowel Disease? A Randomized Controlled Trial.
    McCombie A; Gearry R; Andrews J; Mulder R; Mikocka-Walus A
    Inflamm Bowel Dis; 2016 Jan; 22(1):171-81. PubMed ID: 26360545
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adherence and quality of care in IBD.
    Bager P; Julsgaard M; Vestergaard T; Christensen LA; Dahlerup JF
    Scand J Gastroenterol; 2016 Nov; 51(11):1326-31. PubMed ID: 27311071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus.
    Yan X; Qiao Y; Tong J; Mao R; Liang J; Lv C; Chen Y; Wang Y; Shen J;
    Health Qual Life Outcomes; 2020 Jul; 18(1):241. PubMed ID: 32690091
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fatigue management in patients with IBD: a randomised controlled trial.
    Vogelaar L; van't Spijker A; Timman R; van Tilburg AJ; Bac D; Vogelaar T; Kuipers EJ; van Busschbach JJ; van der Woude CJ
    Gut; 2014 Jun; 63(6):911-8. PubMed ID: 23884638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease.
    Zhen J; Marshall JK; Nguyen GC; Atreja A; Narula N
    J Med Syst; 2021 Jan; 45(2):23. PubMed ID: 33449213
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial.
    Schoultz M; Atherton I; Watson A
    Trials; 2015 Aug; 16():379. PubMed ID: 26303912
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed-methods systematic review.
    Davis SP; Ross MSH; Adatorwovor R; Wei H
    Res Nurs Health; 2021 Feb; 44(1):155-172. PubMed ID: 33305826
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preventive health measures in inflammatory bowel disease.
    Abegunde AT; Muhammad BH; Ali T
    World J Gastroenterol; 2016 Sep; 22(34):7625-44. PubMed ID: 27678347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patients' experiences of an open access follow up arrangement in managing inflammatory bowel disease.
    Rogers A; Kennedy A; Nelson E; Robinson A
    Qual Saf Health Care; 2004 Oct; 13(5):374-8. PubMed ID: 15465941
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of telemedicine in inflammatory bowel disease: a real monitoring option?
    Aguas M; Del Hoyo J; Faubel R; Nos P
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):879-81. PubMed ID: 27291621
    [No Abstract]   [Full Text] [Related]  

  • 71. The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Gerbarg PL; Jacob VE; Stevens L; Bosworth BP; Chabouni F; DeFilippis EM; Warren R; Trivellas M; Patel PV; Webb CD; Harbus MD; Christos PJ; Brown RP; Scherl EJ
    Inflamm Bowel Dis; 2015 Dec; 21(12):2886-96. PubMed ID: 26426148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study.
    Daperno M; Bortoli A; Kohn A; Politi P; Marconi S; Ardizzone S; Cortelezzi CC; Grasso G; Ferraris L; Milla M; Spina L; Guidi L; Losco A; Inserra G; Sablich R; Morganti D; Bodini G; Comberlato M;
    Dig Liver Dis; 2017 Sep; 49(9):997-1002. PubMed ID: 28595949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patient subjective assessment of drug side effects in inflammatory bowel disease.
    Cross RK; Lapshin O; Finkelstein J
    J Clin Gastroenterol; 2008 Mar; 42(3):244-51. PubMed ID: 18223502
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patient Experience and Satisfaction with an e-Health Care Management Application for Inflammatory Bowel Diseases.
    Zand A; Nguyen A; Reynolds C; Khandadash A; Esrailian E; Hommes D
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831502
    [TBL] [Abstract][Full Text] [Related]  

  • 75. E-health in inflammatory bowel diseases: More challenges than opportunities?
    Bossuyt P; Pouillon L; Bonnaud G; Danese S; Peyrin-Biroulet L
    Dig Liver Dis; 2017 Dec; 49(12):1320-1326. PubMed ID: 28899622
    [TBL] [Abstract][Full Text] [Related]  

  • 76. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease.
    Mikocka-Walus AA; Turnbull DA; Moulding NT; Wilson IG; Andrews JM; Holtmann GJ
    BMC Gastroenterol; 2007 Sep; 7():38. PubMed ID: 17892587
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Photovoice as a tool to improve patient-Provider communication in inflammatory bowel disease clinic: A feasibility study.
    Gorbenko KO; Riggs AR; Koeppel B; Phlegar S; Dubinsky MC; Ungaro R; Keefer L
    J Eval Clin Pract; 2022 Feb; 28(1):159-168. PubMed ID: 34382292
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease.
    Rezazadeh Ardabili A; van Esser D; Wintjens D; Cilissen M; Deben D; Mujagic Z; Russ F; Stassen L; Van Bodegraven AA; Wong D; Winkens B; Jonkers D; Romberg-Camps M; Pierik MJ
    J Crohns Colitis; 2023 Jul; 17(7):1079-1088. PubMed ID: 36795060
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.
    Ueno F; Nakayama Y; Hagiwara E; Kurimoto S; Hibi T
    J Gastroenterol; 2017 May; 52(5):555-567. PubMed ID: 27470433
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential effect of a patient-education transition intervention in adolescents with IBD vs. diabetes.
    Schmidt S; Markwart H; Bomba F; Muehlan H; Findeisen A; Kohl M; Menrath I; Thyen U
    Eur J Pediatr; 2018 Apr; 177(4):497-505. PubMed ID: 29340756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.